Resistin and adiponectin in major depression: The association with free cortisol and effects of antidepressant treatment

Journal of Psychiatric Research

Volumn 41, Issue 3-4, 2007, Pages 344-350

  Weber Hamann, Bettina ^a   Kratzsch, Jürgen ^b   Kopf, Daniel ^a   Lederbogen, Florian ^a   Gilles, Maria ^a   Heuser, Isabella ^a,c   Deuschle, Michael ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adiponectin; Antidepressive treatment; Cardiovascular diseases; Follow up; Major depression; Resistin

Indexed keywords

ADIPONECTIN; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; GLUCOSE; HYDROCORTISONE; INSULIN; LORAZEPAM; PAROXETINE; PLACEBO; RESISTIN; ZOLPIDEM;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SIDE EFFECT; TREATMENT DURATION;

ADIPONECTIN; AMITRIPTYLINE; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; HUMANS; HYDROCORTISONE; INSULIN; PAROXETINE; RESISTIN; SALIVA; STATISTICS; TIME FACTORS;

EID: 33845226867     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.01.002     Document Type: Article

References (34)

1. American Psychiatric Association: Diagnostic Criteria from DSM-IV Washington DC: American Psychiatric Association, 1994.
2. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
3. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., et al. Serum resistin (fizz3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism 88 (2003) 5452-5455
4. Deuschle M., Schmider J., Weber B., Standhardt H., Körner A., Lammers H.C., et al. Pulse-dosing and conventional application of doxepin: Effects upon psychopathology and hypothalamus-pituitary-adrenal (HPA) system. Journal of Clinical Psychopharmacology 17 (1997) 156-160
5. Deuschle M., Hamann B., Meichel C., Krumm B., Lederbogen F., Kniest A., Colla M., and Heuser I. Antidepressive treatment with amitriptyline and paroxetine: effects upon saliva cortisol concentrations. Journal of Clinical Psychopharmacology 23 (2003) 201-205
6. Fallo F., Scarda A., Sonino N., Paoletta A., Boscaro M., Pagano C., et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. European Journal of Endocrinology 150 (2004) 339-344
7. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 290 (2002) 1084-1089
8. Glassmann A., and Shapiro P. Depression and the course of coronary artery disease. American Journal of Psychiatry 155 1 (1998) 4-11
9. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23 (1960) 56-62
10. Haugen F., Jorgensen A., Drevon C.A., and Trayhurn P. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. Federation of European Biochemical Societies Letters 507 (2001) 105-108
11. Heilbronn L.K., Rood J., Janderova L., Albu J.B., Kelley D.E., Ravussin E., et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology and Metabolism 89 (2004) 1844-1848
12. Heuser I. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 31 (1998) 10-13
13. Heuser I., Schweiger U., Gotthardt U., Schmider J., Lammers H.C., Dettling M., et al. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry 153 (1996) 93-99
14. Janke J., Engeli S., Gorzelniak K., Luft F.C., and Sharma A.M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obesity Research 10 (2002) 1-5
15. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 85 (2000) 2402-2410
16. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 (1994) 313-333
17. Kresk M., Silha J.V., Jezkova J., Hana V., Marek J., Weiss V., et al. Adipokine levels in Cushing's syndrome; elevated resistine levels in female patients with Cushing's syndrome. Clinical Endocrinology 60 (2004) 350-357
18. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosomatic Medicine 59 (1997) 241-250
19. Lustman P.J., Griffith L.S., Freedland K.E., and Clouse R.E. Fluoxetine for depression in diabetes. Diabetes Care 23 (2000) 618-623
20. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
21. McTernan C.L., McTernan P.G., Harte A.L., Levick P.L., Barnett A.H., and Kumar S. Resistin, central obesity, and type 2 diabetes. The Lancet 359 (2002) 46-47
22. Pecoraro N., Reyes F., Gomez F., Bhargava A., and Dallman M. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 145 (2004) 3754-3762
23. Peters A., Schweiger U., Pellerin L., Hubold C., Oltmanns K.M., Conrad M., et al. The selfish brain: competition for energy resources. 2004 Neuroscience and Biobehavioral Reviews 28 (2004) 143-180
24. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., and Lazar M.A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53 (2004) 1937-1941
25. Shojima N., Sakoda H., Ogihara T., Fujishiro M., Katagiri H., Anai M., et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 51 (2002) 1737-1744
26. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L.G., and Murphy L. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correltations with insulin resistance. European Journal of Endocrinology 149 (2003) 331-335
27. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
28. Thakore J.H., Richards P.J., Reznek R.H., Martin A., and Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biological Psychiatry 41 (1997) 1140-1142
29. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., et al. Hypercoritisolemic depression is associated with increased intra-abdominal fat. Psychosomatic Medicine 64 (2002) 274-277
30. Weber-Hamann B., Kopf D., Lederbogen F., Gilles M., Heuser I., and Colla M. Deuschle: Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance indepressed patients. Neuroendocrinology 81 (2005) 200-204
31. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes. Close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86 (2001) 1930-1935
32. Yokota T., Otitani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
33. Youn B.S., Yu K.Y., Parl H.J., Lee M.S., Min S.S., Youn M.Y., et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 89 (2004) 150-156
34. Zobel A.W., Yassourides A., Frieboes R.M., and Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. American Journal of Psychiatry 156 (1999) 949-951